Tōru Murata

3.7k total citations · 1 hit paper
34 papers, 2.1k citations indexed

About

Tōru Murata is a scholar working on Surgery, Oncology and Radiation. According to data from OpenAlex, Tōru Murata has authored 34 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 8 papers in Oncology and 8 papers in Radiation. Recurrent topics in Tōru Murata's work include Nuclear Physics and Applications (7 papers), Nuclear reactor physics and engineering (7 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). Tōru Murata is often cited by papers focused on Nuclear Physics and Applications (7 papers), Nuclear reactor physics and engineering (7 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). Tōru Murata collaborates with scholars based in Japan, Austria and Netherlands. Tōru Murata's co-authors include Hiroyuki Matsunobu, Tsuneo NAKAGAWA, Osamu Iwamoto, Keiichi SHIBATA, Atsushi ZUKERAN, Takaaki Ohsawa, Satoshi Chiba, Nobuyuki Iwamoto, K. Furutaka and Akira Ichihara and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Journal of Hepatology.

In The Last Decade

Tōru Murata

29 papers receiving 2.1k citations

Hit Papers

JENDL-4.0: A New Library for Nuclear Science and Engineering 2011 2026 2016 2021 2011 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tōru Murata Japan 13 1.4k 1.2k 868 352 236 34 2.1k
Hideo Harada Japan 26 1.1k 0.8× 1.4k 1.1× 432 0.5× 738 2.1× 223 0.9× 312 2.9k
Osamu Iwamoto Japan 25 2.1k 1.5× 2.0k 1.6× 1.1k 1.3× 1.0k 3.0× 281 1.2× 192 3.4k
S. Matsuyama Japan 19 217 0.2× 762 0.6× 182 0.2× 166 0.5× 204 0.9× 193 1.6k
Akifumi Fukumura Japan 22 255 0.2× 1.4k 1.2× 203 0.2× 213 0.6× 1.6k 6.8× 62 2.1k
Hubert Thierens Belgium 38 329 0.2× 1.5k 1.2× 172 0.2× 360 1.0× 1.5k 6.2× 152 4.2k
Takeshi Kai Japan 17 390 0.3× 972 0.8× 359 0.4× 172 0.5× 677 2.9× 69 1.8k
F. Vanhavere Belgium 31 214 0.2× 2.0k 1.6× 480 0.6× 72 0.2× 1.7k 7.2× 225 3.7k
A. Ottolenghi Italy 30 119 0.1× 1.1k 0.9× 203 0.2× 89 0.3× 1.8k 7.5× 143 3.1k
Takeji Sakae Japan 28 140 0.1× 1.6k 1.3× 244 0.3× 268 0.8× 1.4k 6.0× 237 3.0k
Nobuo Shinohara Japan 19 259 0.2× 367 0.3× 171 0.2× 324 0.9× 61 0.3× 105 999

Countries citing papers authored by Tōru Murata

Since Specialization
Citations

This map shows the geographic impact of Tōru Murata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tōru Murata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tōru Murata more than expected).

Fields of papers citing papers by Tōru Murata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tōru Murata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tōru Murata. The network helps show where Tōru Murata may publish in the future.

Co-authorship network of co-authors of Tōru Murata

This figure shows the co-authorship network connecting the top 25 collaborators of Tōru Murata. A scholar is included among the top collaborators of Tōru Murata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tōru Murata. Tōru Murata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murata, Tōru, et al.. (2019). [A Case of Advanced Gastric Cancer Treated Effectively with Combination Chemotherapy of Paclitaxel plus Ramucirumab].. PubMed. 46(8). 1299–1302.
2.
Katakami, Nobuyuki, Toshiyuki Harada, Tōru Murata, et al.. (2017). Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer. Journal of Clinical Oncology. 35(34). 3859–3866. 100 indexed citations
3.
SHIBATA, Keiichi, Osamu Iwamoto, Tsuneo NAKAGAWA, et al.. (2011). JENDL-4.0: A New Library for Nuclear Science and Engineering. Journal of Nuclear Science and Technology. 48(1). 1–30. 1503 indexed citations breakdown →
4.
SHIBATA, Keiichi, Osamu Iwamoto, Tsuneo NAKAGAWA, et al.. (2011). JENDL-4.0: A New Library for Nuclear Science and Engineering. Journal of Nuclear Science and Technology. 48(1). 1–30. 66 indexed citations
5.
Murata, Tōru, et al.. (2011). [A case of spindle cell carcinoma of the breast, in which irinotecan was effective against respiratory failure due to pulmonary metastases].. PubMed. 38(3). 431–4. 2 indexed citations
6.
Fukami, Yasuyuki, et al.. (2009). Efficacy of preoperative dexamethasone in patients with laparoscopic cholecystectomy: a prospective randomized double-blind study. Journal of Hepato-Biliary-Pancreatic Surgery. 16(3). 367–371. 58 indexed citations
7.
Murata, Tōru, et al.. (2009). A case of anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor. Clinical Journal of Gastroenterology. 2(2). 109–114. 9 indexed citations
9.
Fukami, Yasuyuki, et al.. (2007). A CASE OF RECTOSIGMOID CANCER ASSOCIATED WITH JAPANESE SCHISTOSOMIASIS. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 68(3). 632–634. 1 indexed citations
10.
Murata, Tōru, Shigeki Arii, Akira Mori, & Masayuki Imamura. (2003). Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis. Journal of Surgical Research. 114(1). 64–71. 32 indexed citations
11.
Arii, Shigeki, Toshimi Kaido, Akira Mori, et al.. (2002). Heparin accelerates liver regeneration following portal branch ligation in normal and cirrhotic rats with increased plasma hepatocyte growth factor levels. Journal of Hepatology. 37(1). 87–92. 12 indexed citations
12.
SHIBATA, Keiichi, Akira Hasegawa, Osamu Iwamoto, et al.. (2002). JENDL-3.2 Covariance File. Journal of Nuclear Science and Technology. 39(sup2). 40–43. 16 indexed citations
13.
Kawano, Toshihiko, Hiroyuki Matsunobu, Tōru Murata, et al.. (2002). New Evaluations of Heavy Nuclide Data for JENDL-3.3. Journal of Nuclear Science and Technology. 39(sup2). 108–111. 26 indexed citations
14.
Maeda, Atsuyuki, et al.. (2002). Pseudoaneurysm of the cystic artery with hemobilia treated by arterial embolization and elective cholecystectomy. Journal of Hepato-Biliary-Pancreatic Surgery. 9(6). 755–758. 70 indexed citations
15.
Murata, Tōru, Shigeki Arii, Toshio Nakamura, et al.. (2001). Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells. Journal of Hepatology. 35(4). 474–481. 75 indexed citations
16.
Furumoto, Katsuyoshi, Akira Mori, Hiroaki Furuyama, et al.. (2001). Reck Gene Expression in Hepatocellular Carcinoma: Correlation With Invasion–Related Clinicopathological Factors and Its Clinical Significance. Hepatology. 33(1). 189–195. 82 indexed citations
17.
Murata, Tōru, et al.. (2001). A Case of Duodenal Crohn's Disease with a Difficult Preoperative Diagnosis.. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 62(12). 2943–2948. 2 indexed citations
18.
Kanda, Yukinori, Tōru Murata, Masayoshi Kawai, et al.. (1986). Simultaneous evaluation of fission and capture cross sections and their covariances for heavy nuclei. Radiation Effects. 96(1-4). 225–229. 6 indexed citations
19.
Hisatake, Kazuo, et al.. (1964). The 0+ excited state of Ce140 studied by the decay of Pr140. Nuclear Physics. 56. 625–635. 17 indexed citations
20.
Imai, Tetsuya, et al.. (1962). The Hemodynamic and Electrocardiographic Studies in the Incipient Left Heart Failure of the Hypertensive Patients. Japanese Circulation Journal-english Edition. 26(12). 993–994. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026